CashuNuvation Bio Faces Investigation for Alleged Fiduciary Breaches Amid Shareholder Concerns9 months ago
CashuNuvation Bio Launches Access Program for Taletrectinib in ROS1-Positive Lung Cancer Patients10 months ago
CashuNuvation Bio Launches Expanded Access Program for Taletrectinib in ROS1-Positive NSCLC Patients10 months ago
benzinga.comUnited Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesdayabout 2 months ago
businesswire.comNuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung Cancer10 months ago
businesswire.comNuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference11 months ago
businesswire.comNuvation Bio Receives Approval from China’s National Medical Products Administration for Taletrectinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer11 months ago